Showing results (641-650 of 744) with videos related to
Sort By:
Pageof 75
The Journal of Pathology. Clinical Research|October 26, 2021
Diagnostic and prognostic implications of a three-antibody molecular subtyping algorithm for non-muscle invasive bladder cancerChelsea L Jackson, Lina Chen, Céline Sc Hardy, et al.The Prostate|May 13, 2009
Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patientsA Karim Kader, Jielin Sun, Sarah D Isaacs, et al.Journal of Visualized Experiments : Jove|September 2, 2016
Preparation of Formalin-fixed Paraffin-embedded Tissue Cores for both RNA and DNA ExtractionPalak G Patel, Shamini Selvarajah, Suzanne Boursalie, et al.Histopathology|October 10, 2013
An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmapsEva Compérat, Lars Egevad, Antonio Lopez-Beltran, et al.The Journal of Urology|March 3, 2009
Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice GuidelineBarnett S Kramer, Karen L Hagerty, Stewart Justman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2009
Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice GuidelineBarnett S Kramer, Karen L Hagerty, Stewart Justman, et al.The American Journal of Surgical Pathology|July 16, 2014
Best practices recommendations in the application of immunohistochemistry in urologic pathology: report from the International Society of Urological Pathology consensus conferenceMahul B Amin, Jonathan I Epstein, Thomas M Ulbright, et al.American Journal of Clinical Pathology|February 27, 2024
Radical prostatectomy cancer grade and percentage of Gleason pattern 4 estimated by global vs individual tumor grading correlate differently with the risk of biochemical recurrence in Grade Group 2 and 3 cancersOleksandr N Kryvenko, Jonathan I Epstein, Ali Merhe, et al.Clinical Nuclear Medicine|January 24, 2017
Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal MassesSara Sheikhbahaei, Christopher S Jones, Kristin K Porter, et al.The American Journal of Pathology|October 29, 2022
Genomic Characterization of Prostatic Basal Cell CarcinomaJin-Yih Low, Minjeong Ko, Brian Hanratty, et al.Pageof 75